Skip to main content
SpringerLink
Log in

NICE wants more information on rifaximin

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NICE. NICE seeks more information on treatment for potentially serious liver condition. Media Release : 27 Nov 2013. Available from: URL: http://www.nice.org.uk.

  2. NICE. NICE gives green light to ranibizumab for eye condition in final guidance. Media Release : 26 Nov 2013. Available from: URL: http://www.nice.org.uk.

  3. NICE. NICE's 300th technology appraisal guidance recommends drugs to treat chronic hepatitis C in children and young people. Media Release : 26 Nov 2013. Available from: URL: http://www.nice.org.uk.

  4. NICE. NICE recommends new treatment option for multiple sclerosis. Media Release : 6 Dec 2013. Available from: URL: http://www.nice.org.uk.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE wants more information on rifaximin. PharmacoEcon Outcomes News 693, 11 (2013). https://doi.org/10.1007/s40274-013-0949-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0949-6

Search

Navigation